Apheris, T-Systems Enable Secure Clinical Data Research on Sovereign Infrastructure

Apheris federated networks for drug discovery and European healthcare studies can now run on T-Systems’ sovereign infrastructure, with patient data staying inside each hospital.

AbbVie, argenx, Lundbeck and Takeda join Ginkgo Datapoints and Apheris as founding members of the Antibody Developability Consortium, building a standardised dataset of 10,000 antibodies.

AbbVie, Astex, Bristol Myers Squibb, Johnson & Johnson and Takeda trained AISB-1-Fed on more than 20,000 proprietary protein-ligand structures, with only model weights leaving each company.